For Media and Investor Inquiries, contact: Tyler Marciniak,
Vice President of Investor Relations,
Communications and Corporate Operations
We are led by experienced biopharma executives with exceptional track records of building strong, innovative and diverse teams across the healthcare industry.
We are exploring innovative approaches in immunology where we have the opportunity to make a clinically meaningful difference for patients.